225 related articles for article (PubMed ID: 17269912)
1. Iontophoresis - an approach for controlled drug delivery: a review.
Dixit N; Bali V; Baboota S; Ahuja A; Ali J
Curr Drug Deliv; 2007 Jan; 4(1):1-10. PubMed ID: 17269912
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers.
Yamamoto R; Takasuga S; Kominami K; Sutoh C; Kinoshita M; Kanamura K; Takayama K
Chem Pharm Bull (Tokyo); 2013; 61(12):1275-81. PubMed ID: 24292789
[TBL] [Abstract][Full Text] [Related]
3. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
4. Investigation of in vitro iontophoresis facilitated transdermal delivery of glycine.
Dasgupta R; Banthia AK; Tibarewala DN
Curr Drug Deliv; 2009 Apr; 6(2):145-50. PubMed ID: 19450220
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoresis.
Batheja P; Thakur R; Michniak B
Expert Opin Drug Deliv; 2006 Jan; 3(1):127-38. PubMed ID: 16370945
[TBL] [Abstract][Full Text] [Related]
6. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
7. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
9. Iontophoretic drug delivery across human nail.
Narasimha Murthy S; Wiskirchen DE; Bowers CP
J Pharm Sci; 2007 Feb; 96(2):305-11. PubMed ID: 17080425
[TBL] [Abstract][Full Text] [Related]
10. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.
Wang Y; Zeng L; Song W; Liu J
Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687
[TBL] [Abstract][Full Text] [Related]
11. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
12. AC electrokinetic platform for iontophoretic transdermal drug delivery.
Lvovich VF; Matthews E; Riga AT; Kaza L
J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867
[TBL] [Abstract][Full Text] [Related]
13. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide.
Nair V; Panchagnula R
Pharmacol Res; 2003 Aug; 48(2):175-82. PubMed ID: 12798670
[TBL] [Abstract][Full Text] [Related]
15. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
16. Iontophoretic drug delivery system: a review.
Semalty A; Semalty M; Singh R; Saraf SK; Saraf S
Technol Health Care; 2007; 15(4):237-45. PubMed ID: 17673833
[TBL] [Abstract][Full Text] [Related]
17. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
Singh ND; Banga AK
J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
[TBL] [Abstract][Full Text] [Related]
18. Application of design of experiments for formulation development and mechanistic evaluation of iontophoretic tacrine hydrochloride delivery.
Patel N; Jain S; Madan P; Lin S
Drug Dev Ind Pharm; 2016 Nov; 42(11):1894-902. PubMed ID: 27100474
[TBL] [Abstract][Full Text] [Related]
19. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo.
Singhal M; Serna C; Merino V; Kalia YN
Eur J Pharm Biopharm; 2021 Sep; 166():175-181. PubMed ID: 34175373
[TBL] [Abstract][Full Text] [Related]
20. Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.
Singh G; Ghosh B; Kaushalkumar D; Somsekhar V
AAPS PharmSciTech; 2008; 9(3):791-7. PubMed ID: 18592380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
